Sales rise 458.57% to Rs 7.82 crore
Net profit of Parmax Pharma reported to Rs 0.01 crore in the quarter ended June 2024 as against net loss of Rs 1.18 crore during the previous quarter ended June 2023. Sales rose 458.57% to Rs 7.82 crore in the quarter ended June 2024 as against Rs 1.40 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales7.821.40 459 OPM %6.52-46.43 -PBDT0.41-0.76 LP PBT0.01-1.18 LP NP0.01-1.18 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
